Skip to content

Clinical trials

Reperfusion Injury trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Not applicable Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20054
20061
20072
20083
20091
20101
20114
20124
20138
20144
20154
201611
20175
20185
20196
20205
20214
20223
20232
20247
20253
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Unknown status25
Recruiting12
Not yet recruiting7
Withdrawn3
Suspended2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center6
Chinese PLA General Hospital5
Mansoura University3
Medical University of Vienna3
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies2
The Second Hospital of Anhui Medical University2
University of Aarhus2
University of Sao Paulo General Hospital2
University of Zurich2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury97
Myocardial Infarction8
ST Elevation Myocardial Infarction8
Myocardial Reperfusion Injury7
Cardiovascular Diseases4
Ischemia4
Myocardial Ischemia4
Hypothermia3
Ischemic Stroke3
Liver Diseases3

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.